Daniel Cramer

Daniel Cramer has a diverse work experience in various roles and industries. Their most recent position was as the Director of Project Management and Business Development at SpectronRx since June 2020. Prior to that, they worked at Covance as the Expanded Laboratory Manager from April 2018 to June 2020. Daniel also had roles at Zevacor Molecular, where they served as the QC/Regulatory Submissions Manager from November 2017 to March 2018, and as the Regulatory Chemist from August 2013 to November 2017. Previously, they worked at Sigma Tau Pharmasource as a QC Chemistry Analyst 2 from January 2007 to June 2012, and at Enzon Pharmaceuticals as a QC Analyst 1 from 2007 to 2010. Daniel began their career as a Formulation Chemist/ Tech Support at Yushiro Manufacturing America from August 2006 to January 2007.

Daniel Cramer has a diverse education history that spans several institutions and fields of study. Daniel began their formal education at Lansing Community College from 2003 to 2006, where they earned Associate of Applied Science (AAS) degrees in Chemical Technology and Molecular Biotechnology. In 2002, they also completed a Japanese Language and Culture Program at Shiga University, receiving a Certificate of Achievement. Moving forward, Daniel then attended Indiana University–Purdue University Indianapolis from 2011 to 2013, where they pursued a Bachelor's degree in Chemistry with a minor in Japanese Language. Finally, in 2014 and 2015, they attended Purdue University, where they obtained a Graduate Certificate in Biotech Quality and Regulatory Compliance. This educational background showcases their expertise in various scientific and biotechnological fields as well as their linguistic abilities in Japanese.